Criscuolo, E.; De Sciscio, M.L.; De Cristofaro, A.; Nicoara, C.; Maccarrone, M.; Fezza, F.
Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1. Pharmaceuticals 2023, 16, 1678.
https://doi.org/10.3390/ph16121678
AMA Style
Criscuolo E, De Sciscio ML, De Cristofaro A, Nicoara C, Maccarrone M, Fezza F.
Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1. Pharmaceuticals. 2023; 16(12):1678.
https://doi.org/10.3390/ph16121678
Chicago/Turabian Style
Criscuolo, Emanuele, Maria Laura De Sciscio, Angela De Cristofaro, Catalin Nicoara, Mauro Maccarrone, and Filomena Fezza.
2023. "Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1" Pharmaceuticals 16, no. 12: 1678.
https://doi.org/10.3390/ph16121678
APA Style
Criscuolo, E., De Sciscio, M. L., De Cristofaro, A., Nicoara, C., Maccarrone, M., & Fezza, F.
(2023). Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1. Pharmaceuticals, 16(12), 1678.
https://doi.org/10.3390/ph16121678
